Core Facilities

We have built a state-of-the-art antibody development and protein engineering facility. This core offers a range of antibody discovery technologies from classical monoclonal hybridomas through phage-Fab libraries to fully human antibodies derived directly from convalescent patients. Antibody engineering approaches include antibody chimerization (humanization) and conjugation technologies for advanced medical imaging. These services are offered to academic, clinical and industrial partners from inside and outside Singapore. To manage and develop the Antibody Engineering Core Facility, we recruited Dr Qian Xinlei in January 2023.